Galera Therapeutics Announces Preclinical Data Demonstrating Potential of GC4419 to Improve Effectiveness of Radiation While Preventing Normal Tissue Toxicity

World News: . []

MALVERN Pa April 16 2018 GLOBE NEWSWIRE -- Galera Therapeutics Inc a clinical-stage biotechnology company developing drugs targeting oxygen metabolic pathways with the potential to transform cancer radiotherapy today announced that precl inical ...

More news and information about Galera Therapeutics, Inc.

Published By:

Globe Newswire: 21:30 GMT Monday 16th April 2018

Published: .

Search for other references to "galera" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us